Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Omega-3 breakthrough? new trial targets brain health in High-Risk seniors

NCT ID NCT07392723

First seen Feb 06, 2026 · Last updated May 21, 2026 · Updated 18 times

Summary

This study tests a natural omega-3 supplement (ALA) in 20 older adults with mild memory problems and a genetic risk for Alzheimer's (APOE4). The goal is to see if ALA can protect the brain's blood vessels and barrier, potentially slowing or preventing further memory decline. Participants will take the supplement or a placebo for 6 months, with brain scans and memory tests to measure effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rutgers - Institute for Health

    RECRUITING

    New Brunswick, New Jersey, 08901, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.